Anteo Diagnostics (Australia) Profile

AUD 0.001  7.14%

Anteo Diagnostics Summary

Anteo Diagnostics Limited (ADO) is traded on Australian Securities Exchange in Australia. It is located in 4/26 Brandl Street and employs 99 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 19.6 M. Anteo Diagnostics Limited has 1.15 B outstanding shares. ANTEO DIAGNOSTI has accumulated about 798.43 K in cash with (292.93 K) of positive cash flow from operations.
Check Anteo Diagnostics Probability Of Bankruptcy

Anteo Diagnostics Limited Risk Profiles

Key Fundamentals

Anteo Diagnostics Against Markets

Current Ratings

Anteo Diagnostics 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 2% 
Equity ratings for Anteo Diagnostics Limited are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Anteo Diagnostics Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences, clinical diagnostics, and bioseparations markets. Anteo Diagnostics Limited is based in Eight Mile Plains, Australia. Anteo Diagnostics is traded on Australian Securities Exchange in Australia. more
NameAnteo Diagnostics Limited
CEOStefan EnderlingView All
Macroaxis Advice
InstrumentAustralia Stock View All
Business Address4/26 Brandl Street
Foreign Associate  Israel
ExchangeAustralian Securities Exchange
Contact Number61 7 3219 0085
CurrencyAUD - Australian Dollar

Diversify with Anteo Diagnostics Limited

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Anteo Diagnostics Limited to your portfolio


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


Anteo Diagnostics Corporate Directors
Alan Studley Non-Executive Independent Director, CPA
Matthew Sanderson Independent Director
John Hurrell Non-Executive Director, Ph.D